Trial NCT04237649

View at ClinicalTrials.gov 
Org. Study IDs: CKAZ954A12101
Secondary IDs: 2019-002841-39

Last trial update was posted on 2023-09-25

MeSH Interventions

Spartalizumab

MeSH Conditions

Neoplasms

Other Conditions

Solid Tumors

Stopping Reasons

Business reasons

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID